Fig. 4From: An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugsThe percentage of infection from HCV RNA replication after the administration of FR3T3 at a concentration of 10 and 20 μg/mLBack to article page